drugset / Trial / NCT01978938
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy and safety of eravacycline compared with levofloxacin in participants with complicated urinary tract infections (cUTI).
Timeline
- Start
- 2014-10-06
- Primary completion
- 2015-06-03
- Completion
- 2015-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eravacycline | Small molecule | 1.5 mg/kg | Intravenous |
| Subject | Eravacycline | Small molecule | 200 mg | Intravenous |
| Subject | Eravacycline | Small molecule | 250 mg | Intravenous |
| Comparator | Levofloxacin | Small molecule | 750 mg | Intravenous |